Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.

Timothy J. Wilkin, Barbara Taylor, Susan Olender, Scott M. Hammer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The 15th Conference on Retroviruses and Opportunistic Infections maintained its place as the premier meeting for presentation of the state of the art of antiretroviral therapy. This year brought together data on new antiretroviral agents in the pipeline, updated our knowledge base of agents approved in the past year (eg, maraviroc, raltegravir, etravirine), delineated approaches to management of treatment-naive and -experienced patients and the use of drugs for prevention of maternal-to-child transmission, and refined our expanding knowledge of drug resistance. A particular highlight of this year's conference was the progress made in antiretroviral treatment and research in resource-limited settings as reflected in both the number and quality of presentations emanating from the developing world.

Original languageEnglish (US)
Pages (from-to)31-60
Number of pages30
JournalTopics in HIV medicine : a publication of the International AIDS Society, USA
Volume16
Issue number1
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

etravirine
Art Therapy
Anti-Retroviral Agents
Knowledge Bases
Drug Resistance
Mothers
Therapeutics
Research
Pharmaceutical Preparations
Raltegravir Potassium
maraviroc

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy. / Wilkin, Timothy J.; Taylor, Barbara; Olender, Susan; Hammer, Scott M.

In: Topics in HIV medicine : a publication of the International AIDS Society, USA, Vol. 16, No. 1, 04.2008, p. 31-60.

Research output: Contribution to journalArticle

@article{50452d71614343d087604761a11b2423,
title = "Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.",
abstract = "The 15th Conference on Retroviruses and Opportunistic Infections maintained its place as the premier meeting for presentation of the state of the art of antiretroviral therapy. This year brought together data on new antiretroviral agents in the pipeline, updated our knowledge base of agents approved in the past year (eg, maraviroc, raltegravir, etravirine), delineated approaches to management of treatment-naive and -experienced patients and the use of drugs for prevention of maternal-to-child transmission, and refined our expanding knowledge of drug resistance. A particular highlight of this year's conference was the progress made in antiretroviral treatment and research in resource-limited settings as reflected in both the number and quality of presentations emanating from the developing world.",
author = "Wilkin, {Timothy J.} and Barbara Taylor and Susan Olender and Hammer, {Scott M.}",
year = "2008",
month = "4",
language = "English (US)",
volume = "16",
pages = "31--60",
journal = "Topics in antiviral medicine",
issn = "2161-5853",
publisher = "International Antiviral Society",
number = "1",

}

TY - JOUR

T1 - Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.

AU - Wilkin, Timothy J.

AU - Taylor, Barbara

AU - Olender, Susan

AU - Hammer, Scott M.

PY - 2008/4

Y1 - 2008/4

N2 - The 15th Conference on Retroviruses and Opportunistic Infections maintained its place as the premier meeting for presentation of the state of the art of antiretroviral therapy. This year brought together data on new antiretroviral agents in the pipeline, updated our knowledge base of agents approved in the past year (eg, maraviroc, raltegravir, etravirine), delineated approaches to management of treatment-naive and -experienced patients and the use of drugs for prevention of maternal-to-child transmission, and refined our expanding knowledge of drug resistance. A particular highlight of this year's conference was the progress made in antiretroviral treatment and research in resource-limited settings as reflected in both the number and quality of presentations emanating from the developing world.

AB - The 15th Conference on Retroviruses and Opportunistic Infections maintained its place as the premier meeting for presentation of the state of the art of antiretroviral therapy. This year brought together data on new antiretroviral agents in the pipeline, updated our knowledge base of agents approved in the past year (eg, maraviroc, raltegravir, etravirine), delineated approaches to management of treatment-naive and -experienced patients and the use of drugs for prevention of maternal-to-child transmission, and refined our expanding knowledge of drug resistance. A particular highlight of this year's conference was the progress made in antiretroviral treatment and research in resource-limited settings as reflected in both the number and quality of presentations emanating from the developing world.

UR - http://www.scopus.com/inward/record.url?scp=63549130345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63549130345&partnerID=8YFLogxK

M3 - Article

C2 - 18441381

AN - SCOPUS:63549130345

VL - 16

SP - 31

EP - 60

JO - Topics in antiviral medicine

JF - Topics in antiviral medicine

SN - 2161-5853

IS - 1

ER -